Speakers

Sadiqa Mahmood, DDS, MPH

General Manager & Senior Vice President, Life Sciences Business, Health Catalyst

Sadiqa Mahmood, DDS, MPH is the Senior Vice President and General Manager of the Life Sciences business at Health Catalyst and contributes to the overall vision and growth for the company. Sadiqa’s work focuses on identifying and addressing areas of high unmet need for therapeutic development through application of real-world data. She is an advisor to several healthcare organizations and global policy makers. Sadiqa is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health.

Passionate about improving access to care and patient outcomes by leveraging data and healthcare ecosystem, Sadiqa has spent her career at the intersection of medicine, policy, technology, and analytics. Previously she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Sadiqa has been an advocate of collaborative learning system in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation.

She joined Health Catalyst in 2019 as SVP of Medical Affairs. Sadiqa has lived and worked in Asia and UK in addition to the US. She is based in Boston, Massachusetts. Outside of work, she is a Formula 1 fan and races as a member of a local team.

Speaker Sessions

New from Health Catalyst

Level: General Audience
Track:

New offerings from Health Catalyst in Clinical Research, Financial Transformation, and Population Health.

11. Introducing the Health Catalyst Research Network and Touchstone Match: How Clinical Research as a Care Option Can Improve Revenues and Outcomes

Level:
Track:

Collaboration between clinical care and clinical research can lead to higher clinical trial participation—and clinical trials have been shown to increase revenue and improve patient outcomes and satisfaction. Join this session to learn about our world-class Life Sciences offering, which puts insights directly into the hands of researchers and increases research studies at healthcare systems. Our offering includes two components: 1) The Health Catalyst Research Network (HCRN), a curated network of healthcare systems, biopharmaceutical companies, and contract research organizations (CROs), and 2) The Touchstone Match, which includes high-quality, research-grade data to identify patients for clinical research studies—both within your healthcare organization and at other organizations.

11. Introducing the Health Catalyst Research Network and Touchstone Match: How Clinical Research as a Care Option Can Improve Revenues and Outcomes

Level:
Track:

Collaboration between clinical care and clinical research can lead to higher clinical trial participation—and clinical trials have been shown to increase revenue and improve patient outcomes and satisfaction. Join this session to learn about our world-class Life Sciences offering, which puts insights directly into the hands of researchers and increases research studies at healthcare systems. Our offering includes two components: 1) The Health Catalyst Research Network (HCRN), a curated network of healthcare systems, biopharmaceutical companies, and contract research organizations (CROs), and 2) The Touchstone Match, which includes high-quality, research-grade data to identify patients for clinical research studies—both within your healthcare organization and at other organizations.

11. Introducing the Health Catalyst Research Network and Touchstone Match: How Clinical Research as a Care Option Can Improve Revenues and Outcomes

Level:
Track:

Collaboration between clinical care and clinical research can lead to higher clinical trial participation—and clinical trials have been shown to increase revenue and improve patient outcomes and satisfaction. Join this session to learn about our world-class Life Sciences offering, which puts insights directly into the hands of researchers and increases research studies at healthcare systems. Our offering includes two components: 1) The Health Catalyst Research Network (HCRN), a curated network of healthcare systems, biopharmaceutical companies, and contract research organizations (CROs), and 2) The Touchstone Match, which includes high-quality, research-grade data to identify patients for clinical research studies—both within your healthcare organization and at other organizations.

22. Clinical Research: A Look in the Future

Level: General Audience
Track: Industry Outlook Speaker

Sadiqa Mahmood will talk about the latest trends that define clinical research and how they are changing how providers and pharma work together to leverage technology and data. She will assert that to execute on the promise of clinical research, you need a role model to:

  • Improve the quality of data and subsequent insights.
  • Develop high-value, cross-industry learning partnerships.

Sadiqa will make the case that high-value information and high-value cross-industry collaboration pillars will enable a new level of treatment options and better care.

Even if you are not directly involved in research, Sadiqa will share and invite you to consider the benefits and value that clinical research-related activities could bring value to your organization.

28. Providers and Pharma: Building Bridges to Improve Quality of Care

Level: Advanced
Track: Life Sciences

Providers and pharma have traditionally looked at each other as transactional partners, but that is all changing. There is a new spectrum of opportunities available with what providers already do every day to enhance the quality of care, improve operational outcomes, and drive innovation. Hospital systems are currently the most stressed healthcare pillar—providers are feeling the effects of COVID-19 across outcomes, patient experience, finances, and the well-being of the care team. Many challenges are shared between providers and pharma. The pandemic has solidified the need for a strategic long-term partnership to solve these common challenges by building bridges between providers and pharma through data, technology, and shared expertise.

Join this session to discover:

  • The need for provider and pharma partnerships.
  • Where pharma comes in to play for providers.
  • A collaborative framework.
  • Examples of successful partnerships.

Watch HAS 21 Virtual On-Demand.

Replay HAS 21 Virtual

Unsupported Browser

Unfortunately your web browser is out of date. For improved security, speed and the best experience please consider using the latest version of on the following browsers: Google Chrome, Firefox, Edge, Safari, or Opera.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.